Details of the Drug Formulaction

General Information of Drug Formulation (ID: F10674)

• Formulation Name: Irbesartan 150 mg tablet
• Company: Cadila Healthcare; Zydus Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Irbesartan	(DMTP1DC)	Diabetic kidney disease	GB61.Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Calcium stearate	(E00244)	15324	lubricant
Carmellose sodium	(E00625)	Not Available	Disintegrant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Poloxamer 188	(E00645)	Not Available	Emulsifying agent; Solubilizing agent; Surfactant